Search results
Results from the Go Local Guru Content Network
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community.
Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute.
Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia, which led to the development of other chemotherapeutic agents against other malignancies.
Mansfield resident running to support Dana-Farber and the Jimmy Fund - Mansfield, MA - Running the New Balance Falmouth Road Race to support patient care and cancer research at Dana-Farber...
BOSTON – On August 20, Worcester residents will run the 45th annual New Balance Falmouth Road Race to help conquer cancer as a member of Dana-Farber Cancer Institute’s team. Residents include:
Each year, approximately 50 current and former pediatric cancer patients of Dana-Farber’s Jimmy Fund Clinic are paired with DFMC runners as “Patient Partners.”
Jimmy Fund Clinic patient, Darla Holloway, 5, has been named one of the patient partners for the BURGER KING and Valvoline Instant Oil Change A Chance for Kids & Families program.
Kimmie Ng is a physician at Dana–Farber Cancer Institute who is known for her work on colorectal cancer in young patients.
Dana-Farber sits at the center of a wide range of collaborative efforts to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy.
Currently, he is the principal investigator of the Dana-Farber/Harvard Cancer Center NCI SPORE (National Cancer Institute Specialized Program of Research Excellence) in breast cancer. His research group focuses on improving care through the development of new treatment approaches.